Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study
- 22 August 2006
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 152 (3), 493.e1-493.e8
- https://doi.org/10.1016/j.ahj.2006.06.005
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary diseaseAtherosclerosis, 2006
- Elevation of Asymmetrical Dimethylarginine (ADMA) and Coronary Artery Disease in Men with Erectile DysfunctionEuropean Urology, 2005
- Asymmetric Dimethylarginine and the Risk of Cardiovascular Events and Death in Patients With Coronary Artery DiseaseCirculation Research, 2005
- Quantification of ADMA: analytical approachesVascular Medicine, 2005
- Asymmetrical DimethylarginineCirculation, 2004
- Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine DimethylaminohydrolaseArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of ?-arginine and B vitaminsCardiovascular Research, 2003
- State of the ArgCell, 2001
- Protein methylationCurrent Opinion in Cell Biology, 1993
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992